Drugs Made In America Acquisition (DMIIR) Retained Earnings (2024 - 2025)

Drugs Made In America Acquisition's (DMIIR) quarterly Retained Earnings came in at -$17.8 million in Q4 2025, down 11616.53% year-on-year from N/an in Q4 2024, and down 2.86% on a QoQ basis from -$17.3 million in Q3 2025.

Drugs Made In America Acquisition (DMIIR) Retained Earnings (2024 - 2025) Analysis & Trends

Drugs Made In America Acquisition (DMIIR) has 2 years of Retained Earnings data on file, last reported at -$17.8 million in Q4 2025.

  • On a quarterly basis, Retained Earnings fell 11616.53% year-over-year to -$17.8 million in Q4 2025; TTM through Dec 2025 was -$17.8 million, a 11616.53% decrease from a year earlier, with the FY2025 full-year figure at -$17.8 million, down 11616.53% from the prior year.
  • Retained Earnings for Q4 2025 stood at -$17.8 million, down from -$17.3 million in the prior quarter.
  • Over the last five years, Retained Earnings for DMIIR reached as high as -$151719.0 in Q4 2024 and fell as low as -$17.8 million in Q4 2025.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 EQV Ventures Acquisition 480.75 Mn 480.75 Mn - -16.30 Mn
2 Agriculture & Natural Solutions Acquisition 393.29 Mn 393.29 Mn - -29.19 Mn
3 Berto Acquisition 314.56 Mn 314.35 Mn - -12.19 Mn
4 GP-Act III Acquisition 313.66 Mn 313.66 Mn - -14.48 Mn
5 Centurion Acquisition 311.65 Mn 311.65 Mn - -13.79 Mn
6 Republic Digital Acquisition 310.50 Mn 309.63 Mn - -11.82 Mn
7 Siddhi Acquisition Corp (Cayman Islands) 288.97 Mn 288.97 Mn - -16.14 Mn
8 K&F Growth Acquisition 283.42 Mn 283.42 Mn - -9.42 Mn
9 Bold Eagle Acquisition 275.29 Mn 275.29 Mn - -8.10 Mn
10 Drugs Made In America Acquisition - - - -17.78 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 -17.78 Mn
Sep 30, 2025 -17.28 Mn
Dec 31, 2024 -151,719.00